Research Article

You have free access to this content

Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males

  1. Jing Wu1,2,
  2. Carolyn Salisbury1,
  3. Robin Graham2,
  4. Graham Lyons2,
  5. Michael Fenech1,*

Article first published online: 13 APR 2009

DOI: 10.1002/em.20490

Issue

Environmental and Molecular Mutagenesis

Environmental and Molecular Mutagenesis

Volume 50, Issue 6, pages 489–501, July 2009

Additional Information

How to Cite

Wu, J., Salisbury, C., Graham, R., Lyons, G. and Fenech, M. (2009), Increased consumption of wheat biofortified with selenium does not modify biomarkers of cancer risk, oxidative stress, or immune function in healthy Australian males. Environ. Mol. Mutagen., 50: 489–501. doi: 10.1002/em.20490

Author Information

  1. 1

    Nutritional Genomics and Genome Damage Diagnostics Laboratory, CSIRO Human Nutrition, Food Science Australia, Adelaide, South Australia, Australia

  2. 2

    Discipline of Plant and Food Science, School of Agriculture, Food and Wine, University of Adelaide, Glen Osmond, South Australia, Australia

*CSIRO Human Nutrition, PO Box 10041 Gouger Street, Adelaide BC, SA 5000, Australia

Publication History

  1. Issue published online: 1 JUL 2009
  2. Article first published online: 13 APR 2009
  3. Manuscript Accepted: 13 FEB 2009
  4. Manuscript Received: 29 OCT 2008

Funded by

  • National Center of Excellence for Functional Foods (via the National Food Industry Strategy)
  • HarvestPlus/The University of Adelaide
  • The South Australian Grains Industry Trust Fund
  • Laucke Flour Mills

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (368K)

REFERENCES

  • Allen NE,Appleby PN,Roddam AW,Tjønneland A,Johnsen NF,Overvad K,Boeing H,Weikert S,Kaaks R,Linseisen J,Trichopoulou A,Misirli G,Trichopoulos D,Sacerdote C,Grioni S,Palli D,Tumino R,Bueno-de-Mesquita HB,Kiemeney LA,Barricarte A,Larrañaga N,Sánchez MJ,Agudo A,Tormo MJ,Rodriguez L,Stattin P,Hallmans G,Bingham S,Khaw KT,Slimani N,Rinaldi S,Boffetta P,Riboli E,Key TJ. 2008. Plasma selenium concentration and prostate cancer risk: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 88: 1567–1575.
  • Baghurst KI,Record SJ. 1984. A computerised dietary analysis system for use with diet diaries or food frequency questionnaires. Community Health Stud 8: 11–18.
    Direct Link:
  • Baghurst PA,Carman JA,Syrette JA,Baghurst KI,Crocker JM. 1992. Diet, prolactin, and breast cancer. Am J Clin Nutr 56: 943–949.
  • Bjelakovic G,Nikolova D,Simonetti RG,Gluud C. 2004. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet 364: 1219–1228.
  • Bonassi S,Znaor A,Ceppi M,Lando C,Chang WP,Holland N,Kirsch-Volders M,Zeiger E,Ban S,Barale R,Bigatti MP,Bolognesi C,Cebulska-Wasilewska A,Fabianova E,Fucic A,Hagmar L,Joksic G,Martelli A,Migliore L,Mirkova E,Scarfi MR,Zijno A,Norppa H,Fenech M. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28: 625–631.
  • Brinkman M,Reulen RC,Kellen E,Buntinx F,Zeegers MP. 2006. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer 42: 2463–2471.
  • Buss H,Chan TP,Sluis KB,Domigan NM,Winterbourn CC. 1997. Protein carbonyl measurement by a sensitive ELISA method. Free Radic Biol Med 23: 361–366.
  • Cai L,You NC,Lu H,Mu LN,Lu QY,Yu SZ,Le AD,Marshall J,Heber D,Zhang ZF. 2006. Dietary selenium intake, aldehyde dehydrogenase-2 and X-ray repair cross-complementing 1 genetic polymorphisms, and the risk of esophageal squamous cell carcinoma. Cancer 106: 2345–2354.
    Direct Link:
  • Collins A. 2002. The Comet assay—Principles,applications, and limitations. In: DidenkoVV, editor. Methods in Molecular Biology, In Situ Detection of DNA Damage, Methods and Protocols. Totowa, NJ: Humana Press. pp 163–179.
  • Collins AR. 2005. Assays for oxidative stress and antioxidant status: Applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 81(1 Suppl ): 261S–267S.
  • Combs GJr. 2005. Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135: 343–347.
  • Crott JW,Mashiyama ST,Ames BN,Fenech M. 2001. The effect of folic acid deficiency and MTHFR C677T polymorphism on chromosome damage in human lymphocytes in vitro. Cancer Epidemiol Biomarkers Prev 10: 1089–1096.
  • Devaraj S,Mathur S,Basu A,Aung HH,Vasu VT,Meyers S,Jialal I. 2008. A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress. J Am Coll Nutr 27: 267–273.
  • Dotan Y,Lichtenberg D,Pinchuk I. 2004. Lipid peroxidation cannot be used as a universal criterion of oxidative stress. Prog Lipid Res 43: 200–227.
  • El-Zein RA,Fenech M,Lopez MS,Spitz MR,Etzel CJ. 2008. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17: 1111–1119.
  • Fenech M. 1998. Important variables that influence base-line micronucleus frequency in cytokinesis-blocked lymphocytes—A biomarker for DNA damage in human populations. Mutat Res 404: 155–165.
  • Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2: 1084–1104.
  • Foster CB,Aswath K,Chanock SJ,McKay HF,Peters U. 2006. Polymorphism analysis of six selenoprotein genes: Support for a selective sweep at the glutathione peroxidase 1 locus (3p21) in Asian populations. BMC Genet 7: 56.
  • Gromadzinska J,Reszka E,Bruzelius K,Wasowicz W,Akesson B. 2008. Selenium and cancer: Biomarkers of selenium status and molecular action of selenium supplements. Eur J Nutr 47( Suppl 2): 29–50.
  • Gromer S,Eubel JK,Lee BL,Jacob J. 2005. Human selenoproteins at a glance. Cell Mol Life Sci 62: 2414–2437.
  • Gronberg H. 2003. Prostate cancer epidemiology. Lancet 361: 859–864.
  • Hatfield DL,Carlson BA,Xu XM,Mix H,Gladyshev VN. 2006. Selenocysteine incorporation machinery and the role of selenoproteins in development and health. Prog Nucleic Acid Res Mol Biol 81: 97–142.
  • Hu Y,Benya RV,Carroll RE,Diamond AM. 2005. Allelic loss of the gene for the GPX1 selenium-containing protein is a common event in cancer. J Nutr 135(12 Suppl ): 3021S–3024S.
  • Hu YJ,Diamond AM. 2003. Role of glutathione peroxidase 1 in breast cancer: Loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 63: 3347–3351.
  • Karunasinghe N,Ryan J,Tuckey J,Masters J,Jamieson M,Clarke L,Marshall J,Ferguson L. 2004. DNA stability and serum selenium levels in a high-risk group for prostate cancer. Cancer Epidemiol Biomarkers Prev 13: 391–397.
  • Karunasinghe N,Ferguson LR,Tuckey J,Masters J. 2006. Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk. J Nutr 136: 2232–2235.
  • Kimura M,Umegaki K,Higuchi M,Thomas P,Fenech M. 2004. Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134: 48–56.
  • Kirby J,Lyons G,Markkainen M,McLaughlin M. HPLC-(ID)-ICPMS for the determination of selenium species in biofortified grains and biscuits. In: INTERACT 2006,September 24–28, Perth, Western Australia.
  • Koh T-S,Benson T. 1983. Critical re-appraisal of fluorometric method for determination of selenium in biological materials. Anal Chem 66: 918–926.
  • Lippman SM,Klein EA,Goodman PJ,Lucia MS,Thompson IM,Ford LG,Parnes HL,Minasian LM,Gaziano JM,Hartline JA,Parsons JK,Bearden JD3rd,Crawford ED,Goodman GE,Claudio J,Winquist E,Cook ED,Karp DD,Walther P,Lieber MM,Kristal AR,Darke AK,Arnold KB,Ganz PA,Santella RM,Albanes D,Taylor PR,Probstfield JL,Jagpal TJ,Crowley JJ,Meyskens FLJr,Baker LH,Coltman CAJr. 2009. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301: 39–51.
  • Lyons G,Stangoulis J,Graham R. 2003. High-selenium wheat: Biofortification for better health. Nutr Res Rev 16: 45–60.
  • Lyons G,Judson G,Stangoulis J,Palmer L,Jones J,Graham R. 2004. Trends in selenium status of South Australians. Med J Aust 180: 383–386.
  • Lyons G,Judson G,Ortiz-Monasterio I,Genc Y,Stangoulis J,Graham R. 2005a. Selenium in Australia: Selenium status and biofortification of wheat for better health. J Trace Elem Med Biol 19: 75–82.
  • Lyons G,Ortiz-Monasterio I,Stangoulis J,Graham G. 2005b. Selenium concentration in wheat grain: Is there sufficient genotypic variation to use in breeding? Plant Soil 269: 369–380.
  • Misso N,Powers K,Gillon R,Stewart G,Thompson P. 1996. Reduced platelet gutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin Exp Allergy 26: 838–847.
    Direct Link:
  • Mori TA,Croft KD,Puddey IB,Beilin LJ. 1999. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry. Anal Biochem 268: 117–125.
  • Muth CM,Glenz Y,Klaus M,Radermacher P,Speit G,Leverve X. 2004. Influence of an orally effective SOD on hyperbaric oxygen-related cell damage. Free Radic Res 38: 927–932.
  • Pallant J. 2005. SPSS survival manual: A Step by Step Guide to Data Analysis Using SPSS for Windows (Version 12). Crows Nest, NSW: Allen & Unwin.
  • Piperakis SM,Petrakou E,Tsilimigaki S,Sagnou M,Monogiudis E,Haniotakis G,Karkaseli H,Sarikaki E. 2003. Biomonitoring with the comet assay of Greek greenhouse workers exposed to pesticides. Environ Mol Mutagen 41: 104–110.
    Direct Link:
  • Ravn-Haren G,Bugel S,Krath BN,Hoac T,Stagsted J,Jorgensen K,Bresson JR,Larsen EH,Dragsted LO. 2008. A short-term intervention trial with selenate, selenium-enriched yeast and selenium-enriched milk: Effects on oxidative defence regulation. Br J Nutr 99: 883–892.
  • Rayman M. 2000. The importance of selenium to human health. Lancet 356: 233–241.
  • Rayman MP. 2005. Selenium in cancer prevention: A review of the evidence and mechanism of action. Proc Nutr Soc 64: 527–542.
  • Reid ME,Stratton MS,Lillico AJ,Fakih M,Natarajan R,Clark LC,Marshall JR. 2004. A report of high-dose selenium supplementation: Response and toxicities. J Trace Elem Med Biol 18: 69–74.
  • Schnabel R,Lubos E,Messow CM,Sinning CR,Zeller T,Wild PS,Peetz D,Handy DE,Munzel T,Loscalzo J,Lackner KJ,Blankenberg S. 2008. Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) Study. Am Heart J 156: 1201.e1–1201.e11.
  • Umegaki K,Fenech M. 2000. Cytokinesis-block micronucleus assay in WIL2-NS cells: A sensitive system to detect chromosomal damage induced by reactive oxygen species and activated human neutrophils. Mutagenesis 15: 261–269.
  • Verschaeve L,Koppen G,Gorp UV,Schoeters G,Jacobs G,Zwijzen C. 2007. Seasonal variations in spontaneous levels of DNA damage; implication in the risk assessment of environmental chemicals. J Appl Toxicol 27: 612–620.
    Direct Link:
  • Waters D,Shen S,Cooley D,Bostwick D,Qian J,Combs GJr,Glickman L,Oteham C,Schlittler D,Morris J. 2003. Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J Natl Cancer Inst 95: 237–241.
  • Waters DJ,Shen S,Glickman LT,Cooley DM,Bostwick DG,Qian J,Combs GFJr,Morris JS. 2005. Prostate cancer risk and DNA damage: Translational significance of selenium supplementation in a canine model. Carcinogenesis 26: 1256–1262.
  • Watkinson J. 1966. Fluorometric determination of selenium in biological material with 2,3-diaminonaphthalene. Anal Chem 38: 92–97.
  • Wu J,Lyons GH,Graham RD,Fenech MF. The effect of selenium, as selenomethionine, on genome stability and cytotoxicity in human lymphocytes measured using the cytokinesis-block micronucleus cytome assay. Mutagenesis. 2009 Jan 20. [Epub ahead of print].
  • Yang G,Zhou R. 1994. Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China. J Trace Elem Electrolytes Health Dis 8: 159–165.
Get PDF (368K)